Fig. 1
From: Revisiting dose-finding of monoclonal antibodies in migraine
Representation of the percentage inhibition of DBF in response to capsaicin application on the forearm model with increasing doses of erenumab (blue graph, [6]). Based on a study in the forehead model using 70 mg of erenumab (red square, [13]), we extrapolated the forehead DBF responses to a wider range of dosages (pink graph)